Dr. Rivero is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3800 Reservoir Rd NW
Washington, DC 20007Phone+1 202-444-3736Fax+1 202-444-0939
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
Cook County Health and Hospitals SystemResidency, Internal Medicine, 2002 - 2005
OtherClass of 1994
Certifications & Licensure
FL State Medical License 2005 - 2027
TX State Medical License 2012 - 2026
AZ State Medical License 2024 - 2025
IN State Medical License 2024 - 2025
KY State Medical License 2024 - 2025
MD State Medical License 2008 - 2025
DC State Medical License 2023 - 2024- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox. Start of enrollment: 2014 Sep 11
- Sertraline in Treatment of Low-Risk Myelodysplastic Syndrome Start of enrollment: 2015 May 01
Publications & Presentations
PubMed
- 80 citationsWith equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study.Nathanael Fillmore, Sarvari Venkata Yellapragada, Chizoba Ifeorah, Ansh Mehta, Diana Cirstea
Blood. 2019-06-13 - 5 citationsDisparities in mortality among acute myeloid leukemia-related hospitalizations.Sara Taveras Alam, Deepa Dongarwar, Elyse Lopez, Sarvari Yellapragada, Gustavo Rivero
Cancer Medicine. 2023-02-01 - 16 citationsEndemic mycoses in a cancer hospital.Harrys Antonio Torres, Gustavo A. Rivero, Dimitrios P. Kontoyiannis
Medicine. 2002-05-01
Abstracts/Posters
- Differential Induction Among Younger Patients Diagnosed with Secondary Acute Myelogenous Leukemia Is Feasible By Cytogenetic/Molecular Risk StratificationGustavo A. Rivero, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Superior Outcome in Elderly AML Patients Receiving Adjuvant Serotonin-Reuptake-Inhibitors during InductionGustavo A. Rivero, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Clinical Challenges: Optimizing Infection Prophylaxis in AMLSeptember 15th, 2021- A Missed Opportunity in Expanded Access Limits Real-World InsightsJuly 7th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
